Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 3/20 | 0.47 |
| ▸ | MME | P08473 | 9/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 8/20 | 0.47 |
| ▸ | ACE | P12821 | 7/20 | 0.47 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.47 |
| ▸ | PSAT1 | Q9Y617 | 2/20 | 0.47 |
| ▸ | CPA1 | P15085 | 6/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 3/20 | 0.43 |
| ▸ | MMP9 | P14780 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6949191 | 0.80 | NPSR1 (0.62) | MMEACE2ACECPA1NPSR1 | |
| SCHEMBL7517173 | 0.80 | NPSR1 (0.62) | MMEACE2ACECPA1NPSR1 | |
| SCHEMBL28290972 | 0.80 | NPSR1 (0.62) | MMEACE2ACECPA1NPSR1 | |
| SCHEMBL224241 | 0.80 | MAPT (0.39) | NPSR1 | |
| SCHEMBL26909780 | 0.78 | HPGDS (0.58) | HPGDSMMEACE2ACESRR | |
| SCHEMBL4348297 | 0.78 | HPGDS (0.58) | HPGDSMMEACE2ACESRR | |
| SCHEMBL6212171 | 0.78 | NPSR1 (0.52) | MMEACE2ACECPA1NPSR1 | |
| SCHEMBL14343041 | 0.78 | NPSR1 (0.52) | MMEACE2ACECPA1NPSR1 | |
| SCHEMBL13821433 | 0.77 | TAAR1 (0.44) | MMEACESRRPSAT1 | |
| SCHEMBL6414895 | 0.76 | EPHX1 (0.50) | HPGDSMMEACE2ACENPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2070928-A1 | 7-azaindol-3-ylacrylamides active as kinase inhibitors | NERVIANO MEDICAL SCIENCES S.r.l. (IT) | 2009-06-17 | — | — | EP | disclosed |
| EP-2070928-A1 | 7-azaindol-3-ylacrylamides active as kinase inhibitors | NERVIANO MEDICAL SCIENCES S.r.l. (IT) | 2009-06-17 | — | — | EP | disclosed |